Epidemiology of Genitourinary Tract Carcinoma in Siriraj Hospital During 1990-1995

Authors

  • Sonthidej Sivilaikul Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Suchai Soontrapa Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700

Keywords:

Epidemiology, Genitourinary, Tract Carcinoma

Abstract

In Thailand genitourinary tract cancers are not as common as cancers of the liver and lung; but they affect the quality of life, well-being and mortality rate. If detected early, they can be cured by surgery. From the Thai cancer statistics, the incidence of genitourinary cancer ranked the fifth and bladder cancer was the most common.

This report is a retrospective study of genitourinary tract cancers in Siriraj Hospital between 1990 to 1995. The total number of patients with genitourinary tract cancer was 638 with an average of 127.6 patients per year and bladder cancer was the most common (284 patients, 44.5%). The second most common was prostate cancer (191 patients, 29.9%), followed by renal cancer 68 patients (10.6%), penile cancer 50 patients (7.8%), and upper urinary tract cancer 45 patients (7%). Most of the patients were over 60.

Downloads

Published

11-08-2020

How to Cite

Sivilaikul, S. ., & Soontrapa, S. . (2020). Epidemiology of Genitourinary Tract Carcinoma in Siriraj Hospital During 1990-1995. Siriraj Medical Journal, 53(3), 130–137. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/244090

Issue

Vol. 53 No. 3 (2001): March

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.